COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction

Satoshi Kitahara1,2, Masashi Fujino3, Satoshi Honda1

  • 1Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Open Heart
|February 6, 2021
PubMed

Insights

The COVID-19 pandemic led to more mechanical complications in ST-elevation myocardial infarction (STEMI) patients. Public health messaging to stay home may have worsened outcomes by delaying critical care for heart attack symptoms.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Regional reports indicated reduced acute myocardial infarction (AMI) presentations during the COVID-19 pandemic.
  • Little is known about the pandemic's impact on mechanical complications and mortality in ST-elevation myocardial infarction (STEMI) patients.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic on STEMI mechanical complications and mortality.
  • To analyze STEMI patient presentations, mechanical complication incidence, and mortality before and after the pandemic-related state of emergency declaration in Japan.

Main Methods:

  • A single-center retrospective cohort study analyzed STEMI patients.
  • Data included patient presentations, mechanical complications, and mortality.
  • Comparisons were made between the periods before and after the COVID-19 state of emergency declaration (April 7, 2020).

Main Results:

  • Late STEMI presentation increased significantly post-declaration (25.4% vs 14.2%, p=0.03).
  • Mechanical complications rose from 3.6% to 14.3% (p<0.001).
  • In-hospital mortality remained comparable (6.2% vs 6.4%, p=0.95).

Conclusions:

  • The COVID-19 pandemic was associated with an increased incidence of mechanical complications in STEMI patients.
  • Public health guidance to stay home without emphasizing immediate medical attention for heart attack symptoms may have contributed to worse outcomes.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
70
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
288
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
160
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
133
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
101
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95